CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab
Titel:
CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab
Auteur:
Queirolo, Paola Dozin, Beatrice Morabito, Anna Banelli, Barbara Carosio, Roberta Fontana, Vincenzo Ferrucci, Pier Francesco Martinoli, Chiara Cocorocchio, Emilia Ascierto, Paolo A. Madonna, Gabriele Simeone, Ester De Galitiis, Federica Antonini Cappellini, Gian Carlo Marchetti, Paolo Guida, Michele Tommasi, Stefania Ghilardi, Laura Merelli, Barbara Fava, Paolo Osella-Abate, Simona Guidoboni, Massimo Romani, Massimo Ferone, Diego Spagnolo, Francesco Pistillo, Maria Pia